These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 18771008)

  • 1. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with cisplatin.
    Tian J; Pang X; Yu K; Liu L; Zhou J
    Pharmazie; 2008 Aug; 63(8):593-7. PubMed ID: 18771008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
    Zhang Z; Lv H; Zhou J
    Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation of tetrandrine solid lipid nanoparticles].
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):686-9. PubMed ID: 17121232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
    Hu LD; Tang X; Cui FD
    Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
    Li Y; Dong L; Jia A; Chang X; Xue H
    Int J Biol Macromol; 2006 May; 38(3-5):296-9. PubMed ID: 16600362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases.
    Lu B; Xiong SB; Yang H; Yin XD; Chao RB
    Eur J Pharm Sci; 2006 May; 28(1-2):86-95. PubMed ID: 16472996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.
    Yang L; Geng Y; Li H; Zhang Y; You J; Chang Y
    Pharmazie; 2009 Feb; 64(2):86-9. PubMed ID: 19320279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of solid lipid nanoparticles loaded with traditional Chinese medicine by high-pressure homogenization.
    Li YC; Dong L; Jia A; Chang XM; Xue H
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):541-4. PubMed ID: 16762843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and in vitro assessment of paclitaxel loaded lipid nanoparticles formulated using modified solvent injection technique.
    Pandita D; Ahuja A; Velpandian T; Lather V; Dutta T; Khar RK
    Pharmazie; 2009 May; 64(5):301-10. PubMed ID: 19530440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.
    Manjunath K; Venkateswarlu V
    J Control Release; 2005 Oct; 107(2):215-28. PubMed ID: 16014318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation of solid lipid nanoparticles loaded with Xionggui powder-supercritical carbon dioxide fluid extraction and their evaluation in vitro release].
    Chen YJ; Jin RX; Zhou YQ; Zeng J; Zhang H; Feng QR
    Zhongguo Zhong Yao Za Zhi; 2006 Mar; 31(5):376-9. PubMed ID: 16711418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.